Week 24 HBeAg and HBsAg are better predictors of sustained response for Chinese HBeAg positive chronic hepatitis B patients receiving 48 weeks Peginterferon α-2b therapy

被引：0
|
作者：
Yang, Song [1 ]
Xing, Huichun [1 ]
Wang, Qixin [2 ]
Xu, Daozhen [1 ]
Cheng, Jun [1 ]
机构：
[1] Beijing Ditan Hosp, Ctr Hepatol, Beijing, Peoples R China
[2] Merck & Co Inc, Beijing, Peoples R China
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
958
引用
收藏
页码：668A / 668A
页数：1
相关论文
共 50 条
  • [31] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [32] Questioning the sustained response to the interferon therapy in HBeAg(-) chronic hepatitis B
    Akarca, US
    Lebe, E
    Ersoz, G
    Gunsar, F
    Karasu, Z
    Kilincsoy, N
    Celebi, A
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2002, 36 : 96 - 96
  • [33] EXTENDED TREATMENT WITH PEGINTERFERON ALFA-2A BENEFITS PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B WITH A PARTIAL RESPONSE AFTER 48 WEEKS OF THERAPY - CLINICAL EXPERIENCE FROM A CHINESE CENTER
    Zhu, Yue-Yong
    Dong, Jing
    Chen, You-Tao
    Chen, Jing
    Jiang, Jia-ji
    HEPATOLOGY, 2009, 50 (04) : 519A - 520A
  • [34] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    Hepatology International, 2008, 2 : 102 - 110
  • [35] Predictors of response in patients with HBeAG-positive chronic hepatitis B using adefovir dipivoxil therapy
    Li, J.
    Zhao, H.
    Si, C-W.
    Zhang, Y-X.
    Chen, X-Y.
    Wang, L.
    Tang, X-P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S199 - S200
  • [36] QUANTITATIVE HEPATITIS B CORE ANTIBODY LEVEL IS A NEW BASELINE PREDICTOR FOR TREATMENT RESPONSE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING PEGINTERFERON THERAPY
    Wang, G. -Q.
    Hou, F. -Q.
    Song, L. -W.
    Xia, N. -S.
    Yuan, Q.
    Fang, L. -L.
    Ge, S. -X.
    Zhang, J.
    Sun, L.
    Sheng, J. -F.
    Xie, D. -Y.
    Shang, J.
    Wu, S. -H.
    Sun, Y. -T.
    Wei, S. -F.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S439 - S439
  • [37] Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Kwak, Min-Sun
    Cho, Eun Ju
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    DIGESTION, 2011, 84 : 23 - 28
  • [38] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [39] Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
    Ma, Hui
    Yang, Rui-feng
    Wei, Lai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (09) : 1498 - 1506
  • [40] Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon
    Wang, Gui-Qiang
    Hou, FengQin
    Xia, NingShao
    HEPATOLOGY, 2014, 60 : 1110A - 1111A
12345